Europe's drug regulator on Friday (Jun 11) identified another rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it was looking into cases of heart inflammation after inoculation with all coronavirus shots.
Europe's drug regulator on Friday (Jun 11) identified another rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it was looking into cases of heart inflammation after inoculation with all coronavirus shots.